KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $91000.0.

  • Staar Surgical's Exchange Rate Effect fell 9122.47% to $91000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $182000.0, marking a year-over-year decrease of 7147.34%. This contributed to the annual value of -$1.1 million for FY2024, which is 65000.0% down from last year.
  • As of Q3 2025, Staar Surgical's Exchange Rate Effect stood at $91000.0, which was down 9122.47% from $686000.0 recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Exchange Rate Effect ranged from a high of $1.0 million in Q3 2024 and a low of -$937000.0 during Q1 2024
  • Over the past 5 years, Staar Surgical's median Exchange Rate Effect value was -$94500.0 (recorded in 2021), while the average stood at -$70100.0.
  • As far as peak fluctuations go, Staar Surgical's Exchange Rate Effect surged by 68872.18% in 2022, and later crashed by 947000.0% in 2024.
  • Staar Surgical's Exchange Rate Effect (Quarter) stood at -$133000.0 in 2021, then skyrocketed by 688.72% to $783000.0 in 2022, then grew by 10.86% to $868000.0 in 2023, then plummeted by 201.5% to -$881000.0 in 2024, then surged by 110.33% to $91000.0 in 2025.
  • Its Exchange Rate Effect stands at $91000.0 for Q3 2025, versus $686000.0 for Q2 2025 and $286000.0 for Q1 2025.